Non-Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: A Single-Center Study
Authors:
- 10 November 2026
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- p. 1-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register‐based matched cohort studyBritish Journal of Haematology, 2025
- How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasmsBlood, 2025
- Thrombophilia testing: A British Society for Haematology guidelineBritish Journal of Haematology, 2022
- Excess mortality in younger patients with myeloproliferative neoplasmsLeukemia & Lymphoma, 2022
- Clinical insights into the origins of thrombosis in myeloproliferative neoplasmsBlood, 2021
- A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasmsBlood Advances, 2021
- Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNetLeukemia, 2018
- Cerebrovascular events as presenting manifestations of Myeloproliferative NeoplasmRevue Neurologique, 2016
- Myeloproliferative neoplasms and thrombosisBlood, 2013
- JAK2V617F mutation for the early diagnosis of Ph− myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysisBlood, 2009